Saturday
Jan 10th
Home 
FarmavitaR+ Journal Business News Sanofi vs. Lupin
FarmavitaR+ Journal Business News Sanofi vs. Lupin | Sanofi vs. Lupin |
|
|
| Written by Zdravko Mauko | ||||||
| Saturday, 22 July 2006 | ||||||
Lupin loses patent suit about Ramipril in AmericaMUMBAI: Pharmaceutical company Lupin on Thursday said a district court in the US has ruled against the company in a patent infringement suit filed by Sanofi-Aventis and King Pharmaceuticals. “It was a very close call for us and we are disappointed that the Court found the patent to be valid, albeit reluctantly, in the judge’s own words,” said Lupin MD Kamal Sharma. The company plans to appeal this decision to the federal circuit court, Mr Sharma added. The court’s decision followed a suit filed by King Pharmaceuticals and Sanofi-Aventis against Lupin alleging infringement on the ‘5061722’ patent. The trial was completed in June ’06. The court’s decision arises from a suit filed by King Pharmaceuticals and Sanofi-Aventis against the Company alleging patent infringement on the 5061722 patent listed in the FDA’s Orange Book. The trial was completed in June ’06. TIMES NEWS NETWORK [ FRIDAY, JULY 21, 2006 02:38:28 AM]Data and information in this article are from other news sources and is provided for information purposes only. Farmavita.Net shall not be liable for any errors in the content, or for any actions taken in reliance thereon.
Only registered users can write comments! Powered by !JoomlaComment 3.12 Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved.Newer news items
Related Items
                |
||||||
| Last Updated ( Saturday, 22 July 2006 ) | ||||||
| < Prev | Next > |
|---|
- Newsflash
The leader shows that style is no substitute for substance, that creating an impression is not more potent than acting from one's center.
Lao Tzu
- Latest Published
- eCTD for Regulatory Affairs and beyond..
- Czech Republic-yearly maintenance fees
- Sales Force Effectiveness Europe
- European Forecasting Excellence Summit
- Sales Force Effectiveness Europe
- Leading Drug Delivery Companies and Technologies
- Management of Diabetes
- Obesity Drug Markets
- Valuing Pharmaceutical Innovation
- Site Sections
- Popular Pages
3D Content Cloud
BabelFish Translator
Click Flag for Translation
Tag Clouds
historical possible industries subscribers virus major having bring marketed survey young effective called limited anti link identified grow despite people accounting elderly breast described neck dates like self basis compounds
Sponsors
Member Log-in
Who's Online
Registered Users
Subscribe to RSS
Copyright © 2005 - 2009 FarmavitaR+ : Regulatory Affairs Network.
